Abstract:Introduction Bipolar disorder (BD) often has symptoms similar to other mental disorders (BD), and there are no paraclinical criteria for differential diagnosis. (Geoffroy et al. Bip Dis 2017; 5 7). Published work on MD proteomics is scarce and focused on schizophrenia. (Dmitrieva et al. PeerJ. 2022; 10 e13907). Therefore, it is important to study potential biomarkers of BD using easily accessible material—blood serum (Rhee et al. Transl Psy 2023; 13 44). Identification of proteins involved in the pathogenesis of BD will help in the study of the pathogenetic mechanisms of BD, the development of differential diagnostic methods and pathogenetically based drugs. Objectives Carrying out a comparative proteomic analysis of blood serum from patients with BD and healthy individuals to identify potential biomarkers Methods We analyzed the protein spectrum of the blood serum of 14 patients with BD who were admitted during a depressive episode at the age of 32 [21;52] years with a disease duration of 8[5;11] years. The control group consisted of 10 mentally and somatically healthy individuals corresponding to the gender and age of the BD group. Blood serum was purified from 14 major proteins using affinity chromatography and separated by electrophoresis using the Laemmli method. After trypsinolysis, proteins were identified using HPLC/mass spectrometry on an Orbitrap instrument. Mass spectrometric analysis was performed on the Advanced Mass Spectrometry Core Facility of Skolkovo Institute of Science and Technology. Protein identification was carried out using the UniProtKB database using the Mascot search engine. The results were tested for significance using the nonparametric Fisher exact test with Yates correction. Results In patients with BD, qualitative mass spectrometry revealed differential expression of 21 neurospecific proteins. Among them: Protein dispatched homolog 3, Ceroid-lipofuscinosis neuronal protein 6, SWI/SNF complex subunit SMARCC1, Neurogenic differentiation factor 4, Protein furry homolog-like, REST corepressor 1 – are involved in the proliferation, development and differentiation of neurons; Hemicentin-2, Dystrophin, Voltage-dependent L-type calcium channel subunit alpha-1D, Syntaxin-binding protein 5, Small conductance calcium-activated potassium channel protein 1– participate in synaptic transmission of ion transport and form receptors. Conclusions Studying the role of these proteins in BD and their quantitative content in a larger number of patients is promising. This will help in the development of new diagnostic criteria and targets for drug therapy for BD. Support by the Russian Science Foundation grant No. 23-75-00023. Disclosure of Interest None Declared

Evaluating Serum Proteome in Women with Obsessive-Compulsive Disorder/Bipolar Disorder Compared to Pure Obsessive- Compulsive Disorder Subjects and Healthy Controls

Proteomic Analysis Reveals sympathetic system and immune-inflammation biomarkers in serum of drug-free obsessive-compulsive disorder

Itraq-Based Serum Proteomic Analysis Reveals Multifactorial Cellular Function Impairment and Aggravated Systematic Inflammation in Drug-free Obsessive-Compulsive Disorders.

Untargeted Metabolomics Analysis in Drug-Naive Patients with Severe Obsessive-Compulsive Disorder

The Oxidative Status and Na+/K+-ATPase Activity in Obsessive-Compulsive Disorder: A Case Control Study

Proteomic analysis of blood serum in bipolar disorder

Serum Erythropoietin and Ischemic-Modified Albumin Levels in Adolescents with Obsessive–Compulsive Disorder

Differential Expression of Proteins Associated with Bipolar Disorder as Identified Using the PeptideShaker Software

Vitamin D levels in children and adolescents with obsessive compulsive disorder

Platelet Serotonin, Plasma Prolactin and Dexamethasone Suppression Test in Patients with Obsessive-Compulsive Disorder

Metabolic syndrome in patients with obsessive-compulsive disorder

Exploring the role of interleukin-1β and interleukin-6 in the pathophysiology of obsessive-compulsive disorder

Cortical Thickness and White Matter Integrity Abnormalities in Obsessive-Compulsive Disorder: A Combined Multimodal Surface-Based Morphometry and Tract-Based Spatial Statistics Study

Distinct proteomic profiles in prefrontal subareas of elderly major depressive disorder and bipolar disorder patients

The effect of major depressive disorder comorbidity on ischemia-modified albumin levels, a marker of oxidative stress, and antioxidant defense system in patients with obsessive compulsive disorder

The Dynamics of Resting-State EEG and Salivary Trace Elements in Patients with Obsessive-Compulsive Disorder

Serotonergic underpinnings of obsessive‐compulsive disorder: A systematic review and meta‐analysis of neuroimaging findings

Genome-wide Mrna Expression Analysis of Peripheral Blood from Patients with Obsessive-Compulsive Disorder

Psychoimmune Investigation in Obsessive-Compulsive Disorder - Assays of Plasma Transferrin, Il-2 and Il-6 Receptor, and Il-1-Beta and Il-6 Concentrations

Evaluation of Paraoxonase, Arylesterase, Dipeptidyl Peptidase-IV, Oxidative Stress, and Oxidative DNA Damage in Patients with Obsessive-Compulsive Disorder

Evaluation of serum zonulin and occludin levels in obsessive-compulsive disorder and the effect of major depressive disorder comorbidity